Two companies announced on Thursday that the heart disease drug they had been developing failed its Phase III trial.
Two companies announced on Thursday that the heart disease drug they had been developing failed its Phase III trial.
Join thousands of traders and investors. Discover how specific trading strategies work — and get started with your investment journey.
